Fanny Collaud

2.0k citations

32 papers · 1.1k indexed · h-index 18

Impact in

Genetics top 5%
- Virus-based gene therapy research
Molecular Biology top 10%
- CRISPR and Genetic Engineering
- RNA Interference and Gene Delivery
- Viral Infectious Diseases and Gene Expression in Insects

Papers in ⓘ

Genetics 23
- Virus-based gene therapy research 22
Molecular Biology 19
- RNA Interference and Gene Delivery 10
- CRISPR and Genetic Engineering 4
- Biochemical and Molecular Research 4

Co-authors: Giuseppe Ronzitti (26 shared papers)Federico Mingozzi (22 shared papers)Christian Leborgne (10 shared papers)Séverine Charles (14 shared papers)Laetitia van Wittenberghe (13 shared papers)Marcelo Simon Sola (10 shared papers)Solenne Marmier (6 shared papers)Alban Vignaud (5 shared papers)
Journals: Molecular Therapy — Methods & Clinical Development (11 papers)Molecular Therapy (3 papers)Neuromuscular Disorders (3 papers)Scientific Reports (1 paper)Journal of Inherited Metabolic Disease (1 paper)
Partner nations: France United States Italy

In The Last Decade

Fanny Collaud

30 papers receiving 1.1k citations

Peers

Countries citing papers authored by Fanny Collaud

Since Specialization

Citations

This map shows the geographic impact of Fanny Collaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanny Collaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanny Collaud more than expected).

Fields of papers citing papers by Fanny Collaud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fanny Collaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanny Collaud. The network helps show where Fanny Collaud may publish in the future.

Co-authors

The 25 scholars most cited alongside Fanny Collaud, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fanny Collaud Line = papers co-authored together Fanny Collaud links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration Nature Communications ·Amine Meliani, Florence Boisgérault, Romain Hardet, Solenne Marmier, Fanny Collaud, Giuseppe Ronzitti, Christian Leborgne, Helena Costa Verdera, Marcelo Simon Sola, Séverine Charles, Alban Vignaud, Laetitia van Wittenberghe, Giorgia Manni, Olivier D. Christophe, Francesca Fallarino, Christopher Roy, Alicia Michaud, Petr O. Ilyinskii, Takashi Kishimoto, Federico Mingozzi	2018	203
2	Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction Molecular Therapy — Methods & Clinical Development ·Zachary Fitzpatrick, Christian Leborgne, Elena Barbon, Elisa Masat, Giuseppe Ronzitti, Laetitia van Wittenberghe, Alban Vignaud, Fanny Collaud, Séverine Charles, Marcelo Simon Sola, F. Jouen, Olivier Boyer, Federico Mingozzi	2018	136
3	Enhanced liver gene transfer and evasion of preexisting humoral immunity with exosome-enveloped AAV vectors Blood Advances ·Amine Meliani, Florence Boisgérault, Zachary Fitzpatrick, Solenne Marmier, Christian Leborgne, Fanny Collaud, Marcelo Simon Sola, Séverine Charles, Giuseppe Ronzitti, Alban Vignaud, Laetitia van Wittenberghe, Béatrice Marolleau, F. Jouen, Sisareuth Tan, Olivier Boyer, Olivier D. Christophe, Alain Brisson, Casey A. Maguire, Federico Mingozzi	2017	102
4	Capsid-specific removal of circulating antibodies to adeno-associated virus vectors Scientific Reports ·Bérangère Bertin, P. Véron, Christian Leborgne, Jack‐Yves Deschamps, Sophie Moullec, Yves Fromes, Fanny Collaud, Sylvie Boutin, Virginie Latournerie, Laetitia van Wittenberghe, Benoît Delache, Roger Le Grand, Nathalie Dereuddre‐Bosquet, Olivier Benvéniste, Philippe Moullier, Carole Masurier, Otto W. Merten, Federico Mingozzi	2020	80
5	Exposure to wild-type AAV drives distinct capsid immunity profiles in humans Journal of Clinical Investigation ·Klaudia Kuranda, Priscilla Jean-Alphonse, Christian Leborgne, Romain Hardet, Fanny Collaud, Solenne Marmier, Helena Costa Verdera, Giuseppe Ronzitti, P. Véron, Federico Mingozzi	2018	78
6	AAV Gene Transfer with Tandem Promoter Design Prevents Anti-transgene Immunity and Provides Persistent Efficacy in Neonate Pompe Mice Molecular Therapy — Methods & Clinical Development ·Pasqualina Colella, Pauline Sellier, Helena Costa Verdera, Francesco Puzzo, Laetitia van Wittenberghe, Nicolas Guerchet, Nathalie Danièle, Bernard Gjata, Solenne Marmier, Séverine Charles, Marcelo Simon Sola, Isabella Ragone, Christian Leborgne, Fanny Collaud, Federico Mingozzi	2018	54
7	A translationally optimized AAV-UGT1A1 vector drives safe and long-lasting correction of Crigler-Najjar syndrome Molecular Therapy — Methods & Clinical Development ·Giuseppe Ronzitti, Giulia Bortolussi, Remco van Dijk, Fanny Collaud, Séverine Charles, Christian Leborgne, Patrice Vidal, Samia Martin, Bernard Gjata, Marcelo Simon Sola, Laetitia van Wittenberghe, Alban Vignaud, P. Véron, Piter J. Bosma, Andrés F. Muro, Federico Mingozzi	2016	48
8	Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler–Najjar Syndrome Human Gene Therapy ·Sem J. Aronson, P. Véron, Fanny Collaud, Aurélie Hubert, Virginie Delahais, Géraldine Honnet, Robert J. de Knegt, Norman Junge, Ulrich Baumann, Angelo Di Giorgio, Lorenzo D’Antiga, Virginia Maria Ginocchio, Nicola Brunetti‐Pierri, Philippe Labrune, Ulrich Beuers, Piter J. Bosma, Federico Mingozzi	2019	43
9	Prevalence and long-term monitoring of humoral immunity against adeno-associated virus in Duchenne Muscular Dystrophy patients Cellular Immunology ·Christian Leborgne, Virginie Latournerie, Sylvie Boutin, Diana Desgue, Aliénor Quéré, Elodie Pignot, Fanny Collaud, Séverine Charles, Marcelo Simon Sola, Elisa Masat, F. Jouen, Olivier Boyer, Carole Masurier, Federico Mingozzi, P. Véron	2018	41
10	Real-Time Monitoring of Exosome Enveloped-AAV Spreading by Endomicroscopy Approach: A New Tool for Gene Delivery in the Brain Molecular Therapy — Methods & Clinical Development ·Nicola Salvatore Orefice, Benoît Souchet, Jérôme Braudeau, Sandro Alves, Françoise Piguet, Fanny Collaud, Giuseppe Ronzitti, Satoru Tada, Philippe Hantraye, Federico Mingozzi, Frederic Ducongè, Nathalie Cartier	2019	39
11	Progress and challenges of gene therapy for Pompe disease Annals of Translational Medicine ·Giuseppe Ronzitti, Fanny Collaud, Pascal Laforêt, Federico Mingozzi	2019	35
12	Gene Therapy in Patients with the Crigler–Najjar Syndrome New England Journal of Medicine ·Lorenzo D’Antiga, Ulrich Beuers, Giuseppe Ronzitti, Nicola Brunetti‐Pierri, Ulrich Baumann, Angelo Di Giorgio, Sem J. Aronson, Aurélie Hubert, Roberta Romano, Norman Junge, Piter J. Bosma, Giulia Bortolussi, Andrés F. Muro, Ravaka F. Soumoudronga, P. Véron, Fanny Collaud, Nathalie Knuchel-Legendre, Philippe Labrune, Federico Mingozzi	2023	32
13	Development of a dual hybrid AAV vector for endothelial-targeted expression of von Willebrand factor Gene Therapy ·Elena Barbon, Charlotte Kawecki, Solenne Marmier, Aboud Sakkal, Fanny Collaud, Séverine Charles, Giuseppe Ronzitti, Caterina Casari, Olivier D. Christophe, Cécile V. Denis, Peter J. Lenting, Federico Mingozzi	2021	25
14	Rescue of Advanced Pompe Disease in Mice with Hepatic Expression of Secretable Acid α-Glucosidase Molecular Therapy ·Umut Cagin, Francesco Puzzo, Manuel J. Gómez, Maryse Moya‐Nilges, Pauline Sellier, Catalina Abad, Laetitia van Wittenberghe, Nathalie Danièle, Nicolas Guerchet, Bernard Gjata, Fanny Collaud, Séverine Charles, Marcelo Simon Sola, Olivier Boyer, Jacomina Krijnse‐Locker, Giuseppe Ronzitti, Pasqualina Colella, Federico Mingozzi	2020	20
15	Single‐domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitors EMBO Molecular Medicine ·Elena Barbon, Gabriel Aymé, Amel Mohamadi, Jean‐François Ottavi, Charlotte Kawecki, Caterina Casari, Sebastien Verhenne, Solenne Marmier, Laetitia van Wittenberghe, Séverine Charles, Fanny Collaud, Cécile V. Denis, Olivier D. Christophe, Federico Mingozzi, Peter J. Lenting	2020	19
16	Role of Regulatory T Cell and Effector T Cell Exhaustion in Liver-Mediated Transgene Tolerance in Muscle Molecular Therapy — Methods & Clinical Development ·Jérôme Poupiot, Helena Costa Verdera, Romain Hardet, Pasqualina Colella, Fanny Collaud, Laurent Bartolo, Jean Davoust, Peggy Sanatine, Federico Mingozzi, Isabelle Richard, Giuseppe Ronzitti	2019	19
17	Gene therapy with secreted acid alpha-glucosidase rescues Pompe disease in a novel mouse model with early-onset spinal cord and respiratory defects EBioMedicine ·Pasqualina Colella, Pauline Sellier, Manuel J. Gómez, Maria Grazia Biferi, Guillaume Tanniou, Nicolas Guerchet, Mathilde Cohen-Tannoudji, Maryse Moya‐Nilges, Laetitia van Wittenberghe, Nathalie Danièle, Bernard Gjata, Jacomina Krijnse‐Locker, Fanny Collaud, Marcelo Simon‐Sola, Séverine Charles, Umut Cagin, Federico Mingozzi	2020	18
18	Dual muscle-liver transduction imposes immune tolerance for muscle transgene engraftment despite preexisting immunity JCI Insight ·Laurent Bartolo, Stéphanie Li Chung Tong, Pascal Chappert, Dominique Urbain, Fanny Collaud, Pasqualina Colella, Isabelle Richard, Giuseppe Ronzitti, Jocelyne Demengeot, David‐Alexandre Gross, Federico Mingozzi, Jean Davoust	2019	17
19	Efficacy of AAV8-hUGT1A1 with Rapamycin in neonatal, suckling, and juvenile rats to model treatment in pediatric CNs patients Molecular Therapy — Methods & Clinical Development ·Xiaoxia Shi, Sem J. Aronson, Lysbeth ten Bloemendaal, Suzanne Duijst, Robert S. Bakker, Dirk R. de Waart, Giulia Bortolussi, Fanny Collaud, Ronald P.J. Oude Elferink, Andrés F. Muro, Federico Mingozzi, Giuseppe Ronzitti, Piter J. Bosma	2020	15
20	A Quantitative In Vitro Potency Assay for Adeno-Associated Virus Vectors Encoding for the UGT1A1 Transgene Molecular Therapy — Methods & Clinical Development ·Sem J. Aronson, Robert S. Bakker, Sascha Moenis, Remco van Dijk, Giulia Bortolussi, Fanny Collaud, Xiaoxia Shi, Suzanne Duijst, Lysbeth ten Bloemendaal, Giuseppe Ronzitti, Andrés F. Muro, Federico Mingozzi, Ulrich Beuers, Piter J. Bosma	2020	14

About Fanny Collaud

Fanny Collaud is a scholar working on Genetics, Molecular Biology, Physiology, Epidemiology and Genetics, having authored 32 papers that have together received 1.1k indexed citations. Recurring topics across this work include Virus-based gene therapy research (22 papers), RNA Interference and Gene Delivery (10 papers), Lysosomal Storage Disorders Research (8 papers), CAR-T cell therapy research (4 papers), CRISPR and Genetic Engineering (4 papers), Neonatal Health and Biochemistry (4 papers), Biochemical and Molecular Research (4 papers) and Pancreatic function and diabetes (3 papers). The work is most often cited by research in Genetics (705 citations), Molecular Biology (700 citations), Oncology (239 citations), Genetics (74 citations) and Cardiology and Cardiovascular Medicine (151 citations). Fanny Collaud has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Giuseppe Ronzitti, Federico Mingozzi, Christian Leborgne, Séverine Charles, Laetitia van Wittenberghe, Marcelo Simon Sola, Solenne Marmier, Alban Vignaud, Helena Costa Verdera and P. Véron. Their work appears in journals such as Molecular Therapy — Methods & Clinical Development, Molecular Therapy, Neuromuscular Disorders, Scientific Reports and Journal of Inherited Metabolic Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact